GABRIEL LOPEZ to Neoplasms
This is a "connection" page, showing publications GABRIEL LOPEZ has written about Neoplasms.
Connection Strength
0.473
-
Liposomal siRNA nanocarriers for cancer therapy. Adv Drug Deliv Rev. 2014 Feb; 66:110-6.
Score: 0.072
-
Nanotechnology in cancer therapy. J Drug Target. 2013 Dec; 21(10):904-13.
Score: 0.071
-
Nanomedicine based approaches for the delivery of siRNA in cancer. J Intern Med. 2010 Jan; 267(1):44-53.
Score: 0.055
-
Liposomal antisense oligonucleotides for cancer therapy. Methods Enzymol. 2004; 387:241-53.
Score: 0.036
-
GRB2: a pivotal protein in signal transduction. Semin Oncol. 2001 Oct; 28(5 Suppl 16):142-7.
Score: 0.031
-
Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid. Blood. 1996 May 01; 87(9):3650-4.
Score: 0.021
-
Allele-Specific Reprogramming of Cancer Metabolism by the Long Non-coding RNA CCAT2. Mol Cell. 2016 Feb 18; 61(4):520-534.
Score: 0.021
-
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014 Dec 05; 5:5671.
Score: 0.019
-
Therapeutic silencing of KRAS using systemically delivered siRNAs. Mol Cancer Ther. 2014 Dec; 13(12):2876-85.
Score: 0.019
-
A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. Cancer Cell. 2013 Aug 12; 24(2):229-41.
Score: 0.018
-
Tumour angiogenesis regulation by the miR-200 family. Nat Commun. 2013; 4:2427.
Score: 0.017
-
MicroRNA therapeutics: principles, expectations, and challenges. Chin J Cancer. 2011 Jun; 30(6):368-70.
Score: 0.015
-
RNA interference in the clinic: challenges and future directions. Nat Rev Cancer. 2011 Jan; 11(1):59-67.
Score: 0.015
-
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy. 2010 Apr; 6(3):322-9.
Score: 0.014
-
Strategies for in vivo siRNA delivery in cancer. Mini Rev Med Chem. 2008 Mar; 8(3):248-55.
Score: 0.012
-
Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: biochemical, functional, and serological characterization of cytotoxins produced by peripheral blood monocytes isolated by counterflow elutriation. Cancer Res. 1986 Jun; 46(6):2871-5.
Score: 0.011
-
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985 Apr; 151(4):704-10.
Score: 0.010
-
Monocyte subpopulations in angiogenesis. Cancer Res. 2014 Mar 01; 74(5):1287-93.
Score: 0.005
-
Phase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II). Cancer Res. 1990 Jul 15; 50(14):4254-9.
Score: 0.004
-
Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives. Cancer Immunol Immunother. 1986; 21(2):93-9.
Score: 0.003
-
Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. J Clin Oncol. 2005 Dec 10; 23(35):8968-77.
Score: 0.003
-
Mononuclear phagocyte system cytotoxins: a review. Nat Immun Cell Growth Regul. 1985; 4(2):78-89.
Score: 0.002